Views & Analysis Predicting and improving clinical trial enrolment: A problem... Patient enrollment is a common issue across many therapeutic areas in clinical research. Psychiatric disorders in particular represent a tri
R&D Evaluating methods targeting Protein-Protein Interactions Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer.
Views & Analysis Virtual reality therapy: The future of chronic pain manageme... Could virtual reality tools be effective in helping patients ‘unlearn’ their chronic pain?
R&D COVID-19: Celltrion's therapeutic option In just over a year, Celltrion Healthcare says it has identified and delivered a potential treatment for COVID-19.
Views & Analysis Taking steps towards a data-driven future for health and soc... A new policy paper promises to make it easier for innovators and developers to build and deploy tech and AI solution.
Views & Analysis Rare disease: industry, patients and tech join forces on dia... Takeda’s Adam Zaeske discusses how cross-sector collaboration is shaping a brighter future for rare disease diagnosis.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.